Daniel Nadler
Daniel Nadler is an AI founder whose work spans financial analytics and medical search for doctors. He grew up in Toronto, earned a bachelor's degree at the University of Toronto, and completed a PhD in political economy at Harvard. In 2013, he founded Kensho in Harvard Square; S&P Global acquired it in 2018. Around 2022, he launched OpenEvidence, whose AI scored above 90% on the United States Medical Licensing Examination and whose team released DeepConsult, an agent for physicians. TIME named him to its TIME100 Health list in 2025; as co-founder and CEO in 2026, he described plans to help doctors connect patients with clinical trials.
- Now at
- OpenEvidence
Timeline
-
2013–2018
From Toronto to Kensho
He grew up in Toronto, earned a bachelor's degree at the University of Toronto, and completed a PhD in political economy at Harvard. In 2013, he founded Kensho in Harvard Square; its machine-learning and analytics systems served financial institutions and the National Security community.
-
2018
Selling Kensho to S&P
He sold Kensho to S&P Global in 2018.
-
2022
Turning toward medical search
He launched OpenEvidence around 2022 as a medical AI search tool for doctors, applying his information-science experience in finance to clinical research.
-
2023–2025
Testing and extending medical AI
OpenEvidence's AI scored above 90% on the United States Medical Licensing Examination in 2023. In 2025, the company released DeepConsult, an AI agent purpose-built for physicians. Nadler described an ensemble of specialized models trained on peer-reviewed medical literature.
-
2025
A TIME100 Health honor
He was named to TIME100 Health's list of the 100 Most Influential People in global health.
-
As of October 2026
Leading OpenEvidence
He is OpenEvidence's co-founder and CEO.
-
2026
Connecting patients to trials
He described a future plan for OpenEvidence to help doctors match patients with clinical trials.
Sources and credits
Photo: We have no published photo of Daniel Nadler yet. Send us a free-licensed photo.
- This AI founder became a billionaire by building ChatGPT for doctors
- S&P Global to Acquire Kensho; Bolsters Core Capabilities in Artificial Intelligence, Natural Language Processing and Data Analytics - Mar 6, 2018
- Daniel Nadler on Building an AI-Powered Search Engine for Medicine
- OpenEvidence AI Becomes the First AI in History to Score Above 90% on the United States Medical Licensing Examination (USMLE)
- OpenEvidence, the Fastest-Growing Application for Physicians in History, Announces $210 Million Round at $3.5 Billion Valuation
- Daniel Nadler on OpenEvidence: Doctors’ Favorite AI App